Swiss National Bank Acquires 400 Shares of Doximity, Inc. (NASDAQ:DOCS)

Swiss National Bank increased its holdings in Doximity, Inc. (NASDAQ:DOCS) by 0.2% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 216,200 shares of the company’s stock after acquiring an additional 400 shares during the period. Swiss National Bank’s holdings in Doximity were worth $9,420,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in the business. Fountainhead AM LLC purchased a new stake in shares of Doximity in the third quarter worth approximately $710,000. Federated Hermes Inc. raised its position in Doximity by 1,824.5% in the 2nd quarter. Federated Hermes Inc. now owns 279,634 shares of the company’s stock valued at $7,821,000 after buying an additional 265,104 shares during the last quarter. AXA S.A. raised its position in Doximity by 40.2% in the 2nd quarter. AXA S.A. now owns 216,392 shares of the company’s stock valued at $6,052,000 after buying an additional 61,992 shares during the last quarter. Nisa Investment Advisors LLC lifted its stake in Doximity by 15,714.3% during the 2nd quarter. Nisa Investment Advisors LLC now owns 11,070 shares of the company’s stock valued at $310,000 after acquiring an additional 11,000 shares in the last quarter. Finally, Los Angeles Capital Management LLC boosted its holdings in Doximity by 6,242.6% during the 3rd quarter. Los Angeles Capital Management LLC now owns 650,874 shares of the company’s stock worth $28,359,000 after acquiring an additional 640,612 shares during the last quarter. Institutional investors own 87.19% of the company’s stock.

Analyst Ratings Changes

A number of research analysts recently weighed in on DOCS shares. Wells Fargo & Company raised shares of Doximity from an “underweight” rating to an “equal weight” rating and raised their price target for the company from $19.00 to $41.00 in a research report on Friday, November 8th. Canaccord Genuity Group restated a “hold” rating and issued a $60.00 target price (up previously from $40.00) on shares of Doximity in a research note on Wednesday, November 13th. Robert W. Baird increased their price target on Doximity from $41.00 to $45.00 and gave the company an “outperform” rating in a research report on Tuesday, September 17th. JPMorgan Chase & Co. lifted their price target on Doximity from $30.00 to $48.00 and gave the stock a “neutral” rating in a report on Thursday. Finally, Bank of America upped their price objective on Doximity from $32.00 to $45.00 and gave the company a “neutral” rating in a research note on Monday, October 7th. Eleven equities research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $52.27.

Doximity Trading Up 0.4 %

DOCS opened at $48.20 on Monday. Doximity, Inc. has a 12 month low of $22.96 and a 12 month high of $61.75. The company has a market cap of $9.00 billion, a PE ratio of 55.40, a price-to-earnings-growth ratio of 3.89 and a beta of 1.30. The company has a 50 day moving average of $44.64 and a 200 day moving average of $35.16.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.